|
Market Cap (3-Jul) $8,016,640,000 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 55.25 |
EPS 0.14 |
A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around , on 28 October 2024 at 2:26am.
Gift 5 articles to anyone you choose each month when you subscribe. Christian Behrenbruch, the co-founder and chief executive of $7 billion cancer diagnostic giant Telix Pharmaceuticals, has lashed out at Australia’s ability to make next-generation drugs ...
Read ArticleTLX was $11.22 at the close of trade on 30 June 2023
| Recent Articles about ASX:TLX | |
|---|---|
| 2-Jul | Appendix 3G - Telix Pharmaceuticals Limited
company-announcements.afr.com |
| 28-Jun | MONTHLY REPORT May 2025
company-announcements.afr.com |
| 26-Jun | Appendix 3G - Telix Pharmaceuticals Limited
company-announcements.afr.com |
| 26-Jun | Appendix 3G - Telix Pharmaceuticals Limited
company-announcements.afr.com |
| 7-Jun | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| 27-May | Appendix 3H - Notification of cessation of securities
company-announcements.afr.com |
| 27-May | Appendix 2A - Application for quotation of securities
company-announcements.afr.com |
| 21-May | Telix Annual General Meeting Chairman and CEO Addresses
company-announcements.afr.com |
| 21-May | Telix Results of Annual General Meeting
company-announcements.afr.com |
| 21-May | ANNUAL GENERAL MEETING OF SHAREHOLDERS
company-announcements.afr.com |
| Tracked |
Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Telix Pharmaceuticals 